Pharma
Pfizer bets big on genetic research for heart, kidney diseases with Flagship partnership
This is the latest venture in a 10-program deal inked last year between the pharma giant and VC firm.
Drug Discovery
Expert reporting on drug discovery that breaks down the complex issues and emerging trends currently facing healthcare industry leaders.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
